Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
SAGE Open Medicine|January 16, 2016
Credentials for a PharmD graduate: The voyage never endsMohammed Saji Salahudeen, Prasad S NishtalaDrugs & Aging|April 3, 2016
Examination and Estimation of Anticholinergic Burden: Current Trends and Implications for Future ResearchMohammed Saji Salahudeen, Prasad S NishtalaSaudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|March 28, 2017
An overview of pharmacodynamic modelling, ligand-binding approach and its application in clinical practiceMohammed Saji Salahudeen, Prasad S NishtalaClinical Gerontologist|March 16, 2018
A Systematic Review Evaluating the Use of the interRAI Home Care Instrument in Research for Older PeopleMohammed Saji Salahudeen, Prasad S NishtalaGerontology|November 28, 2014
Temporal Trends in Polypharmacy and Hyperpolypharmacy in Older New Zealanders over a 9-Year Period: 2005–2013Prasad S Nishtala, Mohammed Saji SalahudeenTherapeutic Advances in Drug Safety|October 4, 2016
Temporal trends in the use of antidiabetic medicines: a nationwide 9-year study in older people living in New ZealandPrasad S Nishtala, Mohammed Saji SalahudeenExpert Opinion on Drug Safety|March 12, 2016
Anticholinergics: theoretical and clinical overviewPrasad S Nishtala, Mohammed Saji Salahudeen, Sarah N HilmerPlos One|March 22, 2016
Serum Anticholinergic Activity and Cognitive and Functional Adverse Outcomes in Older People: A Systematic Review and Meta-Analysis of the LiteratureMohammed Saji Salahudeen, Te-Yuan Chyou, Prasad S NishtalaDrugs & Aging|February 15, 2014
Impact of anticholinergic discontinuation on cognitive outcomes in older people: a systematic reviewMohammed Saji Salahudeen, Stephen B Duffull, Prasad S NishtalaBMC Geriatrics|April 17, 2015
Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic reviewMohammed Saji Salahudeen, Stephen B Duffull, Prasad S NishtalaPageof 2